NasdaqCM:CLDX
NasdaqCM:CLDXBiotechs

Celldex Therapeutics And 2 Other Undervalued Small Caps With Insider Action In US

The United States market has shown resilience, remaining flat over the last week while achieving a notable 24% increase over the past year, with earnings projected to grow by 15% annually. In this context, identifying promising small-cap stocks like Celldex Therapeutics and others can be key for investors seeking opportunities that align with current market dynamics and insider activity.
NasdaqCM:VABK
NasdaqCM:VABKBanks

3 Dividend Stocks In US Yielding Up To 8.2%

As the U.S. stock market navigates through a week of fluctuating tech earnings and pivotal economic data, investors are keenly observing how these developments influence broader indices like the Dow Jones and S&P 500. In such a dynamic environment, dividend stocks can offer stability by providing consistent income streams, making them an appealing choice for those seeking to balance growth with reliable returns.